Navigation Links
BiO2 Medical Raises $12M in Series C Funding
Date:9/7/2012

SAN ANTONIO, Sept. 7, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently secured $12M in Series C funding. The company worked closely with BiO2 Medical's investment bankers, Pasadera Capital for this Series C round. This funding will allow BiO2 Medical to commercialize the Angel™ Catheter. Remeditex Ventures, LLC led the round along with BiO2 Medical's existing investors.

Christopher E. Banas, BiO2 Medical's Chairman and Chief Executive Officer said, "We are thrilled to have Remeditex join on with BiO2 Medical, as they bring a tremendous amount of experience to the company. We are all looking forward to a successful launch of the Angel™ Catheter which will provide a valuable tool for providing PE prophylaxis in critically ill patients."

"We are excited to be part of the highly qualified BiO2 Medical team. BiO2 has developed a promising product that addresses a significant unmet medical need," said John Creecy, Chief Executive Officer and Director of Remeditex Ventures. "We believe the company is poised to become an important innovator, addressing the needs of patients by substantially reducing the risks associated with pulmonary embolism."

BiO2 Medical's Angel™ Catheter, named after its inventor and BiO2 Medical's Chief Medical Officer, Dr. Luis F. Angel, is a central venous catheter and Inferior Vena Cava (IVC) filter combination device, intended to protect against potentially fatal Pulmonary Embolism (PE) in critically ill patients. The Angel™ Catheter will include a first of its kind prophylactic indication for IVC filter use. For more information regarding BiO2 Medical and the Angel™ Catheter, please visit www.bio2medical.com.


'/>"/>
SOURCE BiO2 Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. As Medical Device Sales Jump in Emerging Markets, Organizations Embrace Outsourcing Clinical Activities
2. Federal Appeals Court Upholds Fraud Verdict Against Cornell University Medical School For Misuse Of NIH Aids Funding
3. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
4. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
5. Medical Alarm Retires Last of Convertible Preferred Stock
6. Concord Medical Responds to Unusual Market Activity in its Stock
7. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
8. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
9. MyEvaluations.com Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
10. Fall Alert Announces Its New Medical Alert Systems Website
11. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):